To: IAHF LIST
Subject: American Media Association: Journalists Fighting the FDA and Corruption in Government in General. I just joined. One of their members being charged with conspiracy for practicing alternative medicine - for using Liquid Deprenyl Citrate- see story below.
From: John Hammell jham@iahf.com
Date: Sat, 06 May 2000 10:46:06 -0400

All Webmasters: Please post.

Everyone: Please forward widely.

Ongoing communication right up until the Codex meeting is necessary- so please keep emailing/phoning the FDA and your congressmen demanding that FDA do more than pay lip service to upholding current US vitamin laws at Codex. (They must not only demand that deliberations on Codex Vitamin Guidelines CEASE PERMANENTLY, but they must ALSO stop trying to build consensus on advancing the Codex vitamin guidelines, which is what they've been doing! They're talking out of two sides of their mouth! They weren't specific as to when their deadline was on comments, but suggested yesterday was it, but you never know with them-so just keep pounding away!

Many THANKS to those of you who have sent donations to help IAHF go to the Codex meeting in Germany June 19-23 for ongoing monitoring. Additional support is needed! Please send your donation to IAHF POB 625 Floyd VA 24091 USA. If you would like to wire money from abroad please let me know.

IAHF LIST:

Upon the strong recommendation of Don Harkins, Publisher of the Idaho Observer, columnist for the Spotlight newspaper which I now also contribute articles to along with Life Extension Magazine, I just joined the AMA, the American Media Association. Please visit their website at http://www.Americanmedia.org/

Having their press pass the next time I venture into the District of Criminals (Washington DC) will be like putting a cross in front of a vampire. From now on, the FDA/Washington Capital Police won't be able to stop me from audiotaping, videotaping, and taking photographs of FDA and Congressional hearings they'd prefer were kept under wraps. (On my last two visits to DC, per the request of the FDA, the Washington Capital Police have been monitoring me and they confiscated my camcorder and tape recorder.)

All the FDA wants you to know about these events is what you can read in their spin controlled media outlets like CNN and AP press releases published in newspapers and broadcast over radio news programs that they control.

I encourage any of you who are journalists to consider also joining the American Media Association, as there is strength in numbers. Don't worry if you don't feel totally ideologically alligned- the point is that no other press association is doing more to expose corruption in government, especially the FDA!

Please especially take note of the following anti FDA article from their website- Please make the call suggested to help Dr. Clyde Reynolds who has been wrongfully charged with conspiracy. Reynolds has been helping Parkinson's patients (and others with degenerative diseases) with liquid deprenyl citrate. Jay Kimball of DEDI, manufacturer of liquid deprenyl citrate is a personal friend of mine and he is being wrongfully persecuted by the FDA as they seek to protect the interests of Somerset Labs- manufacturers of Eldepryl, but he is fighting back hard! I don't know anyone with more raw courage than Jay Kimball. He has been fighting the FDA in court for years. This is a shocking story:
http://www.americanmedia.org/topnews.html

AMA TOP NEWS STORY

Everybody:

One of our members has been indicted for conspiracy. If the truth be told, Dr. Clyde Reynolds has been indicted for conspiracy to heal the sick without FDA approval.

Please pass all of the following info around to anybody who might be interested. We need to create a critical mass of public opinion. Our job as an association should not be taken lightly. While the FDA has the dominant media and the gold mine of U.S. taxpayer dollars with which to persecute us, we only have each other as a defense against them.

This is an SOS not just for Clyde, but for all of the people who have been stricken with Parkinson's and other degenerative diseases and the other alternative health care practitioners who have been successfully treating them. The FDA is persecuting the developers and users of a natural substance called Liquid Deprenyl Citrate (LDC) that is derived from the ephedra plant. After thousands of applications it has been found to cause no ill effects in the long or short term and has helped hundreds of people to have their quality of life returned to them after as long as a decade of "terminal" degeneration under the care of allopaths and "orthodox" therapies.

FDA persecution of LDC users is just the latest in a long line of FDA persecutions against simple, inexpensive therapies and people must start making a stand now or continue to die slow, painful and expensive FDA-approved deaths by FDA-approved drugs.

Please read the following and respond by calling Rande Matteson at the FDA with the number provided below. Matteson will not be able to answer any intelligent questions regarding his agency's decade-long persecution of people who chose to use this amazing substance. It is my hope that the FDA will begin to realize that the nation is watching it and that it will not be able to get away with blocking public access to effective therapies in secrecy.

Let me say that I have no personal financial interest in LDC and my only motivation for forwarding this SOS is because, as a journalist, I have seen the evidence, have talked at length with the developer, have talked at length to Dr. Reynolds and several of his patients and other people all over the country who have used LDC. I have also tried to talk to the FDA, Rande Matteson in particular, but he will not answer any questions.

What you are about to read is the truth as borne out through all of the above.

Do something.
Sincerely,

Don Harkins
The Idaho Observer


Ladies and gentlemen:

Following is an article that describes a current attempt by the FDA to block public access to a very incredible nutritive plant product called Liquid Deprenly Citrate (LDC).

LDC is selegeline that has been stablized with a natural citra gel and, after thousands of applications, there have been zero negative side affects reported. The substance has been used successfully to treat Parkinson's and other degerative diseases.

The FDA-approved equivalent to LDC is a product manufactured by Somerset Pharmaceutical called Eldepryl. Eledpryl is selegeline hydrochloride and has been tested to contain methamphetamine and an, as yet, publicly unidentified neurotoxin. People have died from using this FDA-approved drug.

Though LDC has never been reported to have harmed anybody, the developer of LDC, Jay Kimball, has been in perpetual litigation with the FDA since 1991. Read the article to follow for more details.

Kimball was recently rearrested and the "investigation" has expanded to include Dr. Clyde Reynolds from the Portland, OR, area who has been successfully using LDC for a decade to treat his patients. Dr. Reynolds has never had a complaint.

Dr. Reynolds is, among other things, an unorthodox physician who has the audacity to heal people by means that are not necessarily approved by the FDA. Dr. Reynolds has a cancer control rate of nearly 94 percent. Keep in mind that most of his patients come to him after they have been cut, radiated and/or chemotherapied and have been diagnosed terminal by their allopath. Dr. Reynolds has also been remarkably successful in the treatment of the variety of toxin-induced degenerative diseases that plague 1990s Americans.

We will not even argue the merits of LDC—there is no reason for you to believe what I am saying until you are given the data and have seen for yourselves how incredible this substance is and how beautifully it works with the body to give people the tools to combat for themselves the diseases that ravage their bodies.

What is really at stake here is the FDA's ongoing attempts to abuse its authority to block public access to a product that is less toxic than water—a product that has harmed nobody but has helped hundreds of people to restore their quality of life. At the very least, LDC is harmless.

The FDA will not give even one legitimate reason why it is persecuting these men over the use of this substance. Kimball and Reynolds are both fighters and believe that what they are doing is in the best interest of the American people.

The lead FDA investigator in this matter is Rande Matteson. Call him. Ask him why the public is being denied access to LDC. Matteson can be called at: (954) 476-5434. He will not be able to give you a reason.

The FDA answer to LDC is like the FDA answer to why cancer patients in the U.S. do not have access to laetrile. Whatever their answer, it has nothing to do with science, field experience or the health and well-being of patients.

These men are men of means and are going to battle the bad guys and are getting people lined up to be in their corner. This is a perfect opportunity to show the American people what the FDA is really all about. There will be a meeting in Reno at the end of the month among groups such as Life Extension to discuss strategies that will bring this matter to the forefront and teach the American people a lesson in health freedom and bureaucracy.

Afer reading the following article, if you are interested in more information, please contact me and I will put you in contact with Kimball or Reynolds, who has just been indicted for some kind of conspiracy—apparently conspiracy to heal the sick without the approval of the FDA.

I have been writing on this subject for some time now and I can vouch for the veracity of the information involved, the credibility of the Kimball and Reynolds and the value of LDC to patients who will suffer and/or die without it.

I can be reached at (208) 687-9441.

Sincerely,

Don Harkins, Editor
The Idaho Observer
http://www.proliberty.com/observer/

PS - The purpose of this communication is to make the FDA aware that people are beginnning to understand that its function no longer has anything to do with public safety. Please contact me personally if you have any questions. We have the evidence. The FDA is demonstrably out of line here.

State, federal agents wage war against Florida company

Government confiscated trade secrets alleged to be in competitor files

by Don Harkins
The Idaho Observer

TAMPA - After withstanding nearly a decade of what appears to be a frivolous, harrassive and abusive federally-instigated, multi-jurisdictional investigation (code named "Operation Rx)," a Florida pharmaceutical researcher and manufacturer was allowed to present evidence of state and federal agent criminal conduct to a Florida federal grand jury here May 13, 1999. Discovery Experimental and Development, Inc. (DEDI), President James Kimball seeks grand jury indictments of several state and federal officials for "criminal obstruction of justice, criminal RICO conspiracy, violations of constitutional rights, misuse of grand juries, criminal judicial misconduct and whatever else is criminally legally applicable that a grand jury investigation would reveal," Kimball told the grand jury. Kimball's serious charges stem from the nine-year investigation of himself and his company for developing an effective and marketable form of the naturally-derived nutritive plant product selegiline. "My testimony as to what happened to DEDI and myself will border on the unbelievable, but it will be the truth as I know it," said Kimball in his opening statement.

Kimball presented nearly 6,000 pages of documents to the grand jury in support of his claims that federal prosecutors Philip Halpern and Michael Rubenstein and Food and Drug Administration (FDA) official Dennis Degan conspired with the Florida Office of Statewide Prosecution, the Florida Department of Law Enforcement (FDLE), U.S. Customs, the Internal Revenue Service and the Florida Health and Rehabilitation Service (HRS) to drive DEDI and Kimball out of business and steal DEDI trade secrets. The confiscated (stolen) trade secrets regard the development and production of DEDI's scientific breakthrough selegiline product Liquid Deprenyl Citrate (LDC).

Selegiline is a dopamine-boosting substance that is derived from the ephedra plant and has been used to treat Parkinson's and other degenerative diseases.

Kimball's summary of evidence specifically mentioned HRS (now the Department of Health) employees Jerry Hill, Gregg Jones, Deborah Orr and Attorney Robert Daniti as playing instrumental roles in the federally-directed investigation. Kimball presented 16 exhibits which indicate HRS complicity in "Operation Rx" which include the deposition of HRS Supervisor Jones and his admission that government agents agreed to violate the law and Kimball's constitutional rights prior to the raids of his personal residence and DEDI offices in early 1993. Kimball estimates that over 100 state and federal government employees have participated in this "investigation."

Contaminated Eldepryl

Somerset Pharmaceuticals, owned by Mylan Pharmaceutical and Watson Pharmaceuticals, produced a contaminated selegiline hydrochloride product with the brand name Eldepryl. According to Kimball, the exhibits presented to the grand jury "clearly reveal that the FDA, HRS and Somerset knew that Somerset's product selegiline hydrochloride (Eldepryl) was contaminated with methamphetamine."

The contamination was reported in 1990 by the U.S. Pharmacological Conference, the entity used by the FDA to test products seeking FDA approval. Further studies indicated that Eldepryl also contained other contaminants including the as yet publicly unidentified neurotoxin "Compound X." The grand jury was also provided with the results of the five-year Lee study, published in the New England Medical Journal in 1998, which "revealed a death rate of almost 2 to 1 with Parkinson's patients using FDA approved protocol selegiline hydrochloride with levadopa(Eldepryl) vs. Parkinson's patients using levadopa alone without selegiline hydrochloride." Kimball believes that the contaminants, which are not added to Eldepryl but are a condition of its manufacture, could be "washed out" but that doing so was likely considered by Somerset to be cost prohibitive. Kimball also believes that the purpose of this ongoing "investigation" was to secure DEDI trade secrets regarding the production of LDC so that they could be given illegally to a competing company, Somerset Pharmaceuticals.

Liquid Deprenyl Citrate

The healing properties of the ephedra plant have been documented for centuries.

The ephedra-derived product selegiline had never been manufactured for human use because it looses its effectiveness within an hour. Scientists had tried unsuccessfully for 30 years to "stabilize" selegiline. After five years of research, DEDI was able to stabilize selegiline with a specially formulated citra gel. In 1990, Kimball named his new experimental product Liquid Deprenyl Citrate and sent samples to the University of Toronto for test trials.

The result was a selegiline product that was more effective than any selegiline hydrochloride product ever tested "and adverse side effects were negligible or none," said Kimball.

After researching all applicable state, federal and international commerce laws and determining that LDC could be legally manufactured, sold and used by the public, DEDI invested tremendous time and resources into constructing an international network that would manufacture and market the product worldwide.

Before LDC was even ready to market, Somerset filed complaints against DEDI with the FDA, HRS, U.S. Customs and the Department of Justice. Somerset complaints resulted in Kimball being arrested in December, 1990, for selling LDC.

The case was dismissed prior to trial for lack of evidence - Kimball could not possibly have sold LDC because marketable LDC had not yet been produced. Kimball also believes that the case was dismissed to avoid public disclosure of illegal acts committed by government agents and law enforcement officers during the "investigation" and his subsequent arrest.

The conspiracy

DEDI began producing and selling LDC for the Mexican marketplace in 1991. Under the alleged authority of a grand jury investigation, DEDI and Kimball's personal residence were raided by HRS. The IRS seized all bank accounts under suspicion of alleged money laundering. The U.S. Postal Service opened a mail fraud investigation.

The IRS returned the money but forced Kimball to "sign papers which agreed that I would not sue them for wrongfully confiscating my company's money," said Kimball.

According to Kimball, there was serious gand jury abuse as subpoenaed parties were simply interrogated by government agents and flown home,the damage had been done. Kimball believes the evidence proves that copies of documents seized from his home and business, including personal information and trade secrets protected by law under the veil of a grand jury investigation, were given to HRS and Somerset by the federal prosecutor's office in San Diego.

Somerset filed suit against DEDI in 1993. The case was settled at the request of Somerset which agreed to pay DEDI and Kimball's court costs of $55,000.

"Before the ink was dry on the settlement papers, Somerset applied to the FDA for approval of a product that was almost, if not identical to our product Liquid Deprenyl Citrate," said Kimball.

Kimball explained that DEDI immediately filed suit against Somerset for theft of trade secrets and that the suit has yet to be resolved in court."We sued the prosecuting attorney, U.S customs agentsm irs agets and hrs agents, FDA agents and tool it all othe way through the system to the supreme court. We have learned that all government agents have granted themselves civil prosecutorial immunity," commented a disgusted Kimball.

Connecting the dots

In 1995 DEDI began its investigations into the conspiracies that had forced it to be in perpetual litigation for three years and its trade secrets made available to a marketplace competitor. DEDI, under the authority of its suit against Somerset, began obtaining its immense collection of incriminating documents through the discovery process. "We found that federal 'task force' meetings had been held before DEDI and my home were raided. At these 'federal' task force meetings, we uncovered evidence - evidence that has been submitted to the grand jury - that HRS officials and attorneys and FDLE agents were also in attendance. The Jones deposition and other documents describe how the raid was to be conducted for maximum efficiency," said Kimball.

Florida state law provides that "They [government agents] must knock and announce," before entering a business for inspection, during normal business hours, and that they must identify themselves and their intentions and that the business has the right of refusal. "After all employees had been removed from the premesis by federal agents in the first wave, there wasn't anybody left to identify themselves to. In deposition, several state and federal agents admitted that they did not identify themselves nor did they announce their intention to search the business and the confiscations continued until after 7 p.m., Kimball recalled.

"The government's plan was to get HRS and FDA agents into my home and my business unnoticed as members of the federal task force search team second wave. Once HRS and FDA agents were inside, they could all become HRS inspectors operating illegally under Florida law," explained Kimball. Florida law forbids HRS agents from conducting an inspection of a residence, confirmed by an administrative court. DEDI, with its records, research, chemicals and computer equipment seized, its mail being investigated, its bank accounts confiscated and an injunction placed against its business activities by HRS, was also forced to fight a civil action initiated by Somerset.

Curiously, the FDA, the agency that apparently instigated this total war attack on a small Florida company, filed nothing against DEDI. "They did their job well," commented Kimball, "they conned everybody else into doing their dirty work."

Kimball did mention that the FDA visited all of DEDI's accounts and threatened them with prosecution and legal fees if they planned to continue doing business with DEDI.

The attack waged against DEDI should be familiar to tens of thousands of Americans who have, through no fault of their own, been driven out of business by legions of bureaucrats from endless government agencies. The government obviously attempted to use the combined resources of the American people to drive DEDI out of business and failed. All suits, investigations and injunctions were dropped and the FDA didn't even send DEDI a letter of complaint.

In June, 1997, a federal court ordered the return of all items seized in the 1993 raids. According to Kimball, computers that had been under warranty when seized, were returned damaged with expired warranties. "We were advised that government agencies are immune from having to pay damages. Too bad. You and I would have to pay if we damaged other peoples' goods," said Kimball.

In apparent violation of the court order, not all items have been returned as of this writing.

Kimball filed suit against the state and federal agents. "Again, all agents are immune from damages they cause, even individually," Kimball noted for the grand jury.

DEDI LDC not under FDA jurisdiction

As far as Kimball or the FDA has been able to determine, selegiline has never been considered as a drug either legally or scientifically as rendered into law or as determined by peer reviewed literature. According to the Dietary Supplement Act of 1994, any product not deemed to be a drug prior to 1994 but identified as a supplement prior to 1994 will remain a supplement even if the product is deemed a drug after 1994. The act, according to Kimball, also allows the medical benefits of vitamins, herbs and botanicals to be stated on product labels.

According to its own laws and under the authority of the Dietary Supplement Act, the FDA has no jurisdiction over DEDI's development,production or sale of LDC because the product was deemed a supplement in 1991. Kimball told the grand jury that the FDA will probably attempt to claim that his product selegiline citrate is the same as selegiline hydrochloride (Eldepryl). "Most any person knows that sodium chloride is table salt. Sodium alone is a different entity that will kill you if you ingest it. Common sense. It doesn't take a chemist to figure out that both of them are sodium," said Kimball who added that the same thing goes for selegiline citrate and selegiline hydrochloride.

Regardless of whether or not the FDA has jurisdiction over DEDI, Kimball and the development, production and sale of LDC, Kimball has submitted hundreds of pages of documents in 87 exhibits to the grand jury which illustrate an almost decade-long FDA effort to discredit, destroy and bankrupt DEDI corporately and Kimball personally. One of the exhibits was nearly 3,000 pages of clinical trials reports for deprenyl. According to Kimball, scientists had recognized the value of selegiline for the last 30 years and had attempted unsuccessfully to make the substance stable enough to be marketable. By 1991 DEDI had stabilized pure selegiline with a citrate gel, named the product Liquid Deprenyl Citrate and sent it out for test trials at the University of Toronto.

Available evidence shows that the FDA has been "investigating" Kimball and DEDI since 1990 due to his attempts to develop LDC for the marketplace. "Our theory was that pure selegiline, which is a different chemical entity than selegiline hydrochloride, would be more effective [in the treatment of terminal disease] as hydrochloric acid changes the chemical structure of selegiline," explained Kimball.

"The test results came back much better than any selegiline hydrochloride they had ever tested. LDC effectiveness was far superior and adverse side effects were negligible to none," Kimball explained to the grand jury. According to Kimball, the federal government has implied that if DEDI should even recommend to a friend how to get LDC - even if no money exchanges hands. "That means we have all lost our freedom of speech,Kimball explained to the grand jurors. "If you recommend a product to friends you are now selling it and should somewhere, sometime it be deemed that the product you recommended to your friend be illegal, you are now guilty of a crime," he added.

When asked by the grand jury if Kimball of DEDI had ever been sued, Kimball stated, under oath, that to this day not one consumer has ever filed a complaint from anywhere in the U.S. about the quality or performance of LDC or any other product that DEDI has ever developed or sold. To the contrary, customer comments expound upon the quality of life extending and enhancing virtues of LDC.

Loose ends

Of the five leading causes of preventable death as reported by Public Citizen magazine (May/June, 1994) medical malpractice was the third most frequent killer at 80,000 deaths per year, or one every seven minutes. According to a 1985 report from the University of Southern California, published in The Journal of Clinical and Hospital Pharmacy, the FDA had approved "A list of 37 anticancer drugs with reported carcinocenicity or co-carcinogenicity..."

The December 18, 1996 edition of American Medical News reported that [FDA approved] drugs kill as many as 198,815 people each year, put 8.8 million people into the hospital, account for up to 28 percent of all hospital admissions. The same article estimated pharmaceutical companies revenues at $182 billion annually.

In his opening statement to the grand jury Kimball commented that statistics have been released which rate FDA approved drugs as the sixth largest killer of American citizens.

The FDA is the federal agency that has been charged with dictating what products or procedures you will be permitted to use to save your life or improve the quality of your life. The FDA has been given the authority to oversee the implementation of policies that will punish you for using products and procedures that it has forbidden - even if they save your life or improve your quality of life.

"The FDA not only restricts your right to products and procedures that can save your life, they restrict the information that exists while wiping out any private research company such as ours so they can, as they already do, maintain control of 99 percent of the medical research and the medicinal products that are currently being developed," said Kimball. Kimball, who has also been in contention with the FDA over the approval of other very effective and naturally-derived remedies, including mild silver protein and trans resveratrol, believes that the "trickle down effect" of FDA policy "has directly caused the loss of life of tens of thousands of people in this country."